flexiontherapeutics.com is a domain that was created on 2007-10-29,making it 17 years ago. It has several subdomains, such as ir.flexiontherapeutics.com , among others.
Description:Flexion Therapeutics is a biopharmaceutical company focused on advancing innovative, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA),...
Discover flexiontherapeutics.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
HomePage size: 44.89 KB |
Page Load Time: 0.273173 Seconds |
Website IP Address: 34.208.127.70 |
Center for Biopharmaceutical Education & Training - CBET cbet.acphs.edu |
Blank & McCune, The Real Estate Company search.blankandmccune.com |
Hooked and Company – Hooked and Company subscriptions.earlymoments.com |
Tractor Supply Company - Company Overview corporate.tractorsupply.com |
Business Ethics for APEC SMEs - Biopharmaceutical Sector mcprinciples.apec.org |
Research & Biopharmaceutical Manufacturing - Cytiva (formerly GE Healthcare Life Sciences) bioprocess.gelifesciences.com |
Careers | Pfizer: One of the world's premier biopharmaceutical companies graduateprogramme.pfizercareersuk.com |
Innovative Biopharmaceutical Solutions | Saint-Gobain biopharm.saint-gobain.com |
Global Biopharmaceutical Company - Bristol Myers Squibb coumadin.bmscustomerconnect.com |
Investors | Flexion Therapeutics, Inc. ir.flexiontherapeutics.com |
Pfizer One of the worlds premier biopharmaceutical companies press.pfizer.com |
Parexel Biopharmaceutical Services & Clinical Research sis.parexel.com |
Leading international biopharmaceutical cdmo.mabxience.com |
Media Release https://ir.flexiontherapeutics.com/static-files/c7bdd49c-443b-430c-9217-9fed3e45875a |
united states securities and exchange commission http://ir.flexiontherapeutics.com/static-files/d426c9f7-23f7-4927-8220-486ba0a833b3 |
flexion's lead osteoarthritis drug candidate demonstrates ... http://flexiontherapeutics.com/wp-content/uploads/2014/09/Flexion_FX005_Top-line_Data-Announcement_final_5_30_12.pdf |
req.flexiontherapeutics.com https://req.flexiontherapeutics.com/NewAccountInfo.aspx |
A flexiontherapeutics.com. 3600 IN A 130.211.29.77 |
MX flexiontherapeutics.com. 1800 IN MX 0 flexiontherapeutics-com.mail.protection.outlook.com. |
NS flexiontherapeutics.com. 21600 IN NS ns31.constellix.com. |
TXT flexiontherapeutics.com. 1800 IN TXT ODgkKtqT5OQ9XKyzWVoOW04d52r1VxYvTgw2AtdHZ+DdF3SywmB1aApQlaatzepo0e9a82E42m3VEVKl9aDM6w== |
SOA flexiontherapeutics.com. 86400 IN SOA ns11.constellix.com. dns.constellix.com. 2015010124 43200 3600 1209600 180 |
Server: nginx |
Date: Sun, 30 May 2021 03:18:37 GMT |
Content-Type: text/html; charset=UTF-8 |
Transfer-Encoding: chunked |
Connection: keep-alive |
Keep-Alive: timeout=20 |
Vary: Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie |
X-Frame-Options: SAMEORIGIN |
X-Pingback: https://flexiontherapeutics.com/xmlrpc.php |
Link: https://flexiontherapeutics.com/wp-json/; rel="https://api.w.org/", https://flexiontherapeutics.com/wp-json/wp/v2/pages/28; rel="alternate"; type="application/json", https://flexiontherapeutics.com/; rel=shortlink |
Expires: Sun, 30 May 2021 02:48:26 GMT |
X-Powered-By: WP Engine |
X-XSS-Protection: 1; mode=block |
X-Content-Type-Options: nosniff |
Strict-Transport-Security: max-age=31536000 |
Content-Security-Policy: "default-src * unsafe-inline unsafe-eval data:", X-Cacheable: SHORT |
Cache-Control: max-age=600, must-revalidate |
X-Cache: HIT: 1 |
X-Cache-Group: normal |
Content-Encoding: gzip |
charset="utf-8"/ |
content="width=device-width, initial-scale=1" name="viewport"/ |
content="index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1" name="robots"/ |
content="Flexion Therapeutics is a biopharmaceutical company focused on advancing innovative, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), a type of degenerative arthritis." name="description"/ |
content="en_US" property="og:locale"/ |
content="website" property="og:type"/ |
content="Home - Flexion - a biopharmaceutical company" property="og:title"/ |
content="Flexion Therapeutics is a biopharmaceutical company focused on advancing innovative, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), a type of degenerative arthritis." property="og:description"/ |
content="https://flexiontherapeutics.com/" property="og:url"/ |
content="Flexion Therapeutics" property="og:site_name"/ |
content="2019-01-23T14:39:27+00:00" property="article:modified_time"/ |
content="summary" name="twitter:card"/ |
Ip Country: United States |
City Name: Boardman |
Latitude: 45.8234 |
Longitude: -119.7257 |
Transformative Medicine... Where It Matters COVID-19 Update Who We Are Core Principles & Values Executive Committee Board of Directors Corporate Social Responsibility Our Product Our Pipeline FX201 FX301 Our Science Unmet Need in Osteoarthritis Clinical Trials and Associated Publications Clinical Trial Interest Research Programs Investigator-Initiated Research Request for Proposal News Press Releases Investors Events & Presentations Corporate Governance Financials & Filings Stock Information Analyst Coverage Contact Us Careers Our Culture Benefits Contact Clinical Trial Interest Medical Information Request Form Partnering Patient Expanded Access Report a Compliance Matter COVID-19 Update IMPACT OF OA Osteoarthritis (OA) is a degenerative disease that affects more than 30 million Americans and accounts for more than $185 billion in annual expenditures. Learn More OUR PRODUCT A non-opioid, extended-release, intra-articular injection that employs our proprietary microsphere technology to treat OA knee pain. Read More OUR SCIENCE We are tireless in our pursuit of innovative science which holds the potential to transform the treatment of musculoskeletal conditions. Learn More OUR PIPELINE Flexion’s strategy is to build a robust pipeline of locally administered therapies to address musculoskeletal conditions, with an initial focus on OA. See the Pipeline Join Our Team Flexion Therapeutics prides itself on finding great talent, rewarding hard work and maintaining a culture that is unparalleled. Learn More © 2021, Flexion Therapeutics Inc. 781.305.7777 Website Design & Development by Graphic Beans Terms of Use Sitemap Privacy Policy Connect with...
Domain Name: FLEXIONTHERAPEUTICS.COM Registry Domain ID: 1306174672_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2022-10-02T00:36:16Z Creation Date: 2007-10-29T15:50:42Z Registry Expiry Date: 2029-10-29T15:50:42Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS11.CONSTELLIX.COM Name Server: NS21.CONSTELLIX.COM Name Server: NS31.CONSTELLIX.COM Name Server: NS41.CONSTELLIX.NET Name Server: NS51.CONSTELLIX.NET Name Server: NS61.CONSTELLIX.NET DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T21:43:27Z <<<